Nanoplasmonics Enabling Cancer Diagnostics and Therapy: History
View Latest Version
Please note this is an old version of this entry, which may differ significantly from the current revision.
Contributor:
Ren A. Odion
,
Yang Liu
,
Tuan Vo-Dinh

Advances in the state of the art for early cancer detection and therapy have led to a paradigm shift in the way the disease is detected and treated. In particular, treatments have become much more targeted and localized to minimize systemic body-wide side effects common in traditional treatment methods such as chemotherapy. At the forefront of this revolution is the utilization of plasmonic gold nanoparticles, which have gained increasing attention as a highly effective nanoplatform ranging from drug delivery to plasmonics-enhanced treatments such as photothermal therapy.

  • plasmonics
  • gold nanostar
  • photothermal
  • immunotherapy

1. Introduction

Cancer has become one of the most deadly diseases throughout the world, with nearly 2 million new cases and over half a million deaths in the U.S. in 2022 alone [1][2]. Of the more deadly cancers, glioblastoma (GBM), is an especially devastating cancer of the brain [3][4]. GBM patient survival rate is a rather dismal at 15 months, even after treatments such as surgery, chemotherapy, and X-ray radiotherapy (XRT) [3][4]. Despite enormous efforts, GBM is still a deadly disease with essentially 100% mortality, urging for new treatment methods. Cancer detection has traditionally relied on techniques that can penetrate thick tissue and produce images that delineate non-tumor tissue from normal tissue based on its structure and density. Modalities such as computed tomography (CT) and magnetic resonance imaging (MRI) are particularly effective in delineating tumor masses from normal tissue, as cancer tissue often has an abnormal tissue density compared with its local environment [5][6]. However, these modalities are often limited as they require highly trained doctors and technicians who can interpret CT and MRI data to make a diagnosis. Additionally, these methods require further interrogations of suspected tumors via histopathology to ascertain the presence of cancerous growth [7].
To overcome these issues, optical modalities that probe the biomolecular composition of the tissue itself have been developed to non-invasively diagnose cancer. Methods such as absorption, fluorescence, and Raman spectroscopy are all modalities that can probe for the unique biochemical composition of cancer tissue, allowing for in vivo imaging that provides a high molecular specificity [8][9][10][11][12][13][14]. The absorption and scattering optical properties are distinct in different tissues and serve as the contrasting property of modalities such as diffuse optical tomography (DOT) [9][15]. On the other hand, fluorescence arises from the sum of different metabolic fluorescence molecules, which can serve as an effective indicator for tumor tissues that have abnormal metabolic rates [10]. Raman spectroscopy is the most specific as the spectral fingerprint of a molecule will have unique Raman peaks at specific Raman shift values.
All of these methods can be utilized with minimal equipment and training, and thus could be useful for rapid diagnostic imaging. However, intrinsic signal differences between tumor and non-tumor tissue can be noisy. In the case of Raman spectroscopy, other sources of signals such as fluorescence may overwhelm the weak Raman scattering signal [16]. One way to overcome this limitation is to use a fluorescent or Raman dye targeted to the tumor [17][18][19]. This can be achieved with methods such as antibody targeting, but recently, nanoparticles have become an ideal choice as a delivery platform as they can take advantage of the enhanced permeation and retention (EPR) effect in which the leaky vasculature of tumor sites allows for nanoparticle accumulation to the local tumor site [17][20]. Additionally, the use of gold, which is a biocompatible material, allows for flexible chemical conjugation of drugs or dyes into these particles, allowing for multifunctional uses of detection and treatment [18][21][22]. Gold nanoparticles, such as gold nanoshells, have been used for photothermal ablation of prostate tumors in clinical trials with no significant toxicities [23]. In addition, a first-in-human clinical study of RNA interference-based spherical nucleic acids, which consist of gold nanoparticle cores, was conducted in patients with recurrent glioblastoma and it revealed no grade 4 or 5 treatment-related toxicities [24]. Finally, these metallic nanoparticles have a unique absorption signature that makes them ideal for targeted thermal therapy [20][25][26].

2. Plasmonic Nanoparticles for Tumor Imaging and Treatment

Plasmonic-active nanosystems such as metallic nanostructures and nanoparticles have recently seen a wide usage of applications ranging from diagnostics to therapy. Plasmonics is a field associated with the induced oscillation of conduction electrons found in metallic nanoscale structures using a source such as laser light. These electron oscillations, or surface plasmons, produce a secondary electromagnetic field that augments the incident electromagnetic field, resulting in a large electromagnetic field around the nanostructure. Numerous plasmonic-active nanoparticles of different geometric shapes and metallic compositions have been developed for tumor imaging. Gold nanospheres have also been used and have seen applications ranging from photothermal generation to drug delivery [27][28][29]. They have also been used as the core to larger nanoparticle constructs used in multimodal applications such as in ultrasound and photoacoustic imaging coupled with fluorescence [30][31]. Other particles such as the gold nanoshell are specifically tuned to near IR absorption to allow for reaching maximal in-depth tissue for cancer therapy [23][27][32][33][34]. Among the nanoparticles with different morphologies and shapes, GNS is among the most effective nanoplatforms for its unique star-shaped geometry and optical tunability [35][36][37]. The plasmonic E-field enhancement is concentrated around the tips of each star, which act as a “lightning rod” that greatly exceeds the enhancement of smoother particles such as nanospheres [38][39]. This electromagnetic (EM) field greatly increases Raman scattering near the surface of the metal in what is known as surface-enhanced Raman scattering (SERS), allowing for chemical species adsorbed on or near the surface of the metal to have a very strong Raman signal. Researchers' laboratory has developed a variety of metallic nanoparticles for SERS applications in chemical analysis, sensing, and diagnostics [40][41][42][43]. This EM field enhancement around the nanoparticle manifests in a highly absorbing nanoparticle that has a high photon-to-heat conversion [17].
As a demonstration of theranostics, researchers developed a specially designed multifunctional gold nanostar with multiple functionalities in detection (SERS, MRI, CT, and TPL) and photothermal treatment (PTT), allowing for pre-operative macroscopic imaging as well as photothermal therapy for post-operative treatment [18]. Furthermore, our group has specifically developed a surfactant-free fabrication of GNS unlike many other similar gold nanoparticle synthesis methods [37][39]. This allows for an even greater biocompatibility for in vivo applications. Additionally, the surface can easily be functionalized with a variety of other reporters for imaging modalities such as MRI [18].

3. Photothermal Therapy (PTT)

The GNS nanoparticles’ multiple sharp branches result in tip-enhanced plasmonics for imaging and PTT [44][45][46]. Upon irradiation with a laser light source, the surface electrons on the metal are thrown into oscillations and induce a strong EM force field. These oscillating plasmons can be roughly modeled after the Drude model of electric conduction at the nanometer scale. Previously, researchers' group developed several models with finite element software (COMSOL Multiphysics) to determine the bulk absorption profile across different wavelengths [38][44][46]. This is particularly important as optical tuning of GNS is possible by controlling the amount of gold or silver added in the synthesis of the particles, and the peak absorption can be red or blue shifted depending on the final size of the particles [35][37][39]. For example, adding more silver chloride reactant in the synthesis notably red-shifts the peak absorption [39]. To this end, researchers developed GNS targeted at the near-infrared (NIR) spectral range (700–1100 nm) within the so-called “tissue optical window”, which corresponds to the wavelength range of least absorption by the tissue [35][37][44].
The thermal treatment of tumors can be achieved conventionally using microwave or high-intensity focused ultrasound. However, such methods are not suitable for deep-seated tumors and off-target heating is often a problem. To circumvent this issue, researchers utilize GNS to take advantage of the EPR effect and only allowed GNS to accumulate around the tumor tissue. As gold nanoparticles are relatively inert, off-target accumulation is not a concern and PTT will only occur in tissue directly irradiated by the laser. This NIR window is particularly important as targeting this range allows for maximal tissue penetration by the traveling photons and minimal absorption around the surrounding tissue. By using the accumulated GNS as the heat nanogenerators selectively absorbed inside tumors via the EPR effect, rather than heating the entire tissue itself, off-target heating can be greatly reduced.

This entry is adapted from the peer-reviewed paper 10.3390/cancers14235737

References

  1. Thun, M.J.; DeLancey, J.O.; Center, M.M.; Jemal, A.; Ward, E.M. The Global Burden of Cancer: Priorities for Prevention. Carcinogenesis 2010, 31, 100–110.
  2. Siegel, R.L.; Miller, K.D.; Fuchs, H.E.; Jemal, A. Cancer Statistics, 2022. CA. Cancer J. Clin. 2022, 72, 7–33.
  3. Hanif, F.; Muzaffar, K.; Perveen, K.; Malhi, S.M.; Simjee, S.U. Glioblastoma Multiforme: A Review of Its Epidemiology and Pathogenesis through Clinical Presentation and Treatment. Asian Pac. J. Cancer Prev. APJCP 2017, 18, 3–9.
  4. Alexander, B.M.; Cloughesy, T.F. Adult Glioblastoma. J. Clin. Oncol. 2017, 35, 2402–2409.
  5. Filler, A.; Filler, A. The History, Development and Impact of Computed Imaging in Neurological Diagnosis and Neurosurgery: CT, MRI, and DTI. Nat. Preced. 2009.
  6. Burton, S.; Brown, G.; Daniels, I.R.; Norman, A.R.; Mason, B.; Cunningham, D. MRI Directed Multidisciplinary Team Preoperative Treatment Strategy: The Way to Eliminate Positive Circumferential Margins? Br. J. Cancer 2006, 94, 351–357.
  7. Perkins, A.; Liu, G. Primary Brain Tumors in Adults: Diagnosis and Treatment. Am. Fam. Physician 2016, 93, 211–217.
  8. Kong, S.G.; Martin, M.E.; Vo-Dinh, T. Hyperspectral Fluorescence Imaging for Mouse Skin Tumor Detection. ETRI J. 2006, 28, 770–776.
  9. Palmer, G.M.; Zhu, C.; Breslin, T.M.; Xu, F.; Gilchrist, K.W.; Ramanujam, N. Comparison of Multiexcitation Fluorescence and Diffuse Reflectance Spectroscopy for the Diagnosis of Breast Cancer (March 2003). IEEE Trans. Biomed. Eng. 2003, 50, 1233–1242.
  10. Liu, Q.; Grant, G.; Li, J.; Zhang, Y.; Hu, F.; Li, S.; Wilson, C.; Chen, K.; Bigner, D.; Vo-Dinh, T. Compact Point-Detection Fluorescence Spectroscopy System for Quantifying Intrinsic Fluorescence Redox Ratio in Brain Cancer Diagnostics. J. Biomed. Opt. 2011, 16, 037004.
  11. Keller, M.D.; Wilson, R.H.; Mycek, M.A.; Mahadevan-Jansen, A. Monte Carlo Model of Spatially Offset Raman Spectroscopy for Breast Tumor Margin Analysis. Appl. Spectrosc. 2010, 64, 607–614.
  12. Desroches, J.; Jermyn, M.; Pinto, M.; Picot, F.; Tremblay, M.-A.; Obaid, S.; Marple, E.; Urmey, K.; Trudel, D.; Soulez, G.; et al. A New Method Using Raman Spectroscopy for in Vivo Targeted Brain Cancer Tissue Biopsy. Sci. Rep. 2018, 8, 1792.
  13. Caspers, P.J.; Lucassen, G.W.; Puppels, G.J. Combined In Vivo Confocal Raman Spectroscopy and Confocal Microscopy of Human Skin. Biophys. J. 2003, 85, 572–580.
  14. Everall, N.J. Confocal Raman Microscopy: Common Errors and Artefacts. Analyst 2010, 135, 2512.
  15. Palmer, G.M.; Ramanujam, N. Monte Carlo-Based Inverse Model for Calculating Tissue Optical Properties. Part I: Theory and Validation on Synthetic Phantoms. Appl. Opt. 2006, 45, 1062–1071.
  16. Chisanga, M.; Muhamadali, H.; Ellis, D.I.; Goodacre, R. Enhancing Disease Diagnosis: Biomedical Applications of Surface-Enhanced Raman Scattering. Appl. Sci. 2019, 9, 1163.
  17. Liu, Y.; Ashton, J.R.; Moding, E.J.; Yuan, H.; Register, J.K.; Fales, A.M.; Choi, J.; Whitley, M.J.; Zhao, X.; Qi, Y.; et al. A Plasmonic Gold Nanostar Theranostic Probe for In Vivo Tumor Imaging and Photothermal Therapy. Theranostics 2015, 5, 946–960.
  18. Liu, Y.; Chang, Z.; Yuan, H.; Fales, A.M.; Vo-Dinh, T. Quintuple-Modality (SERS-MRI-CT-TPL-PTT) Plasmonic Nanoprobe for Theranostics. Nanoscale 2013, 5, 12126.
  19. Liu, Y.; Carpenter, A.B.; Pirozzi, C.J.; Yuan, H.; Waitkus, M.S.; Zhou, Z.; Hansen, L.; Seywald, M.; Odion, R.; Greer, P.K.; et al. Non-Invasive Sensitive Brain Tumor Detection Using Dual-Modality Bioimaging Nanoprobe. Nanotechnology 2019, 30, 275101.
  20. Liu, Y.; Carpenter, A.; Yuan, H.; Zhou, Z.; Zalutsky, M.; Vaidyanathan, G.; Yan, H.; Vo-Dinh, T. Gold Nanostar as Theranostic Probe for Brain Tumor Sensitive PET-Optical Imaging and Image-Guided Specific Photothermal Therapy. Cancer Res. 2016, 76, 4213.
  21. Kim, M.; Lee, J.-H.; Nam, J.-M. Plasmonic Photothermal Nanoparticles for Biomedical Applications. Adv. Sci. 2019, 6, 1900471.
  22. Liu, Y.; Yuan, H.; Kersey, F.R.; Register, J.K.; Parrott, M.C.; Vo-Dinh, T. Plasmonic Gold Nanostars for Multi-Modality Sensing and Diagnostics. Sensors 2015, 15, 3706–3720.
  23. Rastinehad, A.R.; Anastos, H.; Wajswol, E.; Winoker, J.S.; Sfakianos, J.P.; Doppalapudi, S.K.; Carrick, M.R.; Knauer, C.J.; Taouli, B.; Lewis, S.C.; et al. Gold Nanoshell-Localized Photothermal Ablation of Prostate Tumors in a Clinical Pilot Device Study. Proc. Natl. Acad. Sci. USA 2019, 116, 18590–18596.
  24. Kumthekar, P.; Ko, C.H.; Paunesku, T.; Dixit, K.; Sonabend, A.M.; Bloch, O.; Tate, M.; Schwartz, M.; Zuckerman, L.; Lezon, R.; et al. A First-in-Human Phase 0 Clinical Study of RNA Interference–Based Spherical Nucleic Acids in Patients with Recurrent Glioblastoma. Sci. Transl. Med. 2021, 13, eabb3945.
  25. Chorniak, E.; Liu, Y.; Odion, R.; Etienne, W.; Canning, A.; Nair, S.K.; Maccarini, P.; Palmer, G.M.; Inman, B.A.; Vo-Dinh, T. Intravital Optical Imaging for Immune Cell Tracking after Photoimmunotherapy with Plasmonic Gold Nanostars. Nanotechnology 2022, 33, 475101.
  26. Liu, Y.; Maccarini, P.; Palmer, G.M.; Etienne, W.; Zhao, Y.; Lee, C.-T.; Ma, X.; Inman, B.A.; Vo-Dinh, T. Synergistic Immuno Photothermal Nanotherapy (SYMPHONY) for the Treatment of Unresectable and Metastatic Cancers. Sci. Rep. 2017, 7.
  27. Harris, N.; Ford, M.J.; Cortie, M.B. Optimization of Plasmonic Heating by Gold Nanospheres and Nanoshells. J. Phys. Chem. B 2006, 110, 10701–10707.
  28. Near, R.D.; Hayden, S.C.; Hunter, R.E.; Thackston, D.; El-Sayed, M.A. Rapid and Efficient Prediction of Optical Extinction Coefficients for Gold Nanospheres and Gold Nanorods. J. Phys. Chem. C 2013, 117, 23950–23955.
  29. Liu, J.; Ong, W.; Román, E.; Lynn, M.J.; Kaifer, A.E. Cyclodextrin-Modified Gold Nanospheres. Langmuir 2000, 16, 3000–3002.
  30. Fernandes, D.A.; Appak-Baskoy, S.; Berndl, E.; Kolios, M.C. Laser Activatable Perfluorocarbon Bubbles for Imaging and Therapy through Enhanced Absorption from Coupled Silica Coated Gold Nanoparticles. RSC Adv. 2021, 11, 4906–4920.
  31. Fernandes, D.A.; Fernandes, D.D.; Malik, A.; Gomes, G.-N.W.; Appak-Baskoy, S.; Berndl, E.; Gradinaru, C.C.; Kolios, M.C. Multifunctional Nanoparticles as Theranostic Agents for Therapy and Imaging of Breast Cancer. J. Photochem. Photobiol. B 2021, 218, 112110.
  32. Jain, P.K.; El-Sayed, M.A. Universal Scaling of Plasmon Coupling in Metal Nanostructures: Extension from Particle Pairs to Nanoshells. Nano Lett. 2007, 7, 2854–2858.
  33. Loo, C.; Lin, A.; Hirsch, L.; Lee, M.-H.; Barton, J.; Halas, N.; West, J.; Drezek, R. Nanoshell-Enabled Photonics-Based Imaging and Therapy of Cancer. Technol. Cancer Res. Treat. 2004, 3, 33–40.
  34. Norton, S.J.; Vo-Dinh, T. Plasmon Resonances of Nanoshells of Spheroidal Shape. IEEE Trans. Nanotechnol. 2007, 6, 627–638.
  35. Khoury, C.G.; Vo-Dinh, T. Gold Nanostars For Surface-Enhanced Raman Scattering: Synthesis, Characterization and Optimization. J. Phys. Chem. C 2008, 112, 18849–18859.
  36. Fales, A.M.; Yuan, H.; Vo-Dinh, T. Silica-Coated Gold Nanostars for Combined Surface-Enhanced Raman Scattering (SERS) Detection and Singlet-Oxygen Generation: A Potential Nanoplatform for Theranostics. Langmuir 2011, 27, 12186–12190.
  37. De Silva Indrasekara, A.S.; Johnson, S.F.; Odion, R.A.; Vo-Dinh, T. Manipulation of the Geometry and Modulation of the Optical Response of Surfactant-Free Gold Nanostars: A Systematic Bottom-Up Synthesis. ACS Omega 2018, 3, 2202–2210.
  38. Vo-Dinh, T.; Dhawan, A.; Norton, S.J.; Khoury, C.G.; Wang, H.-N.; Misra, V.; Gerhold, M.D. Plasmonic Nanoparticles and Nanowires: Design, Fabrication and Application in Sensing. J. Phys. Chem. C 2010, 114, 7480–7488.
  39. Yuan, H.; Khoury, C.G.; Hwang, H.; Wilson, C.M.; Grant, G.A.; Vo-Dinh, T. Gold Nanostars: Surfactant-Free Synthesis, 3D Modelling, and Two-Photon Photoluminescence Imaging. Nanotechnology 2012, 23, 075102.
  40. Vo-Dinh, T.; Hiromoto, M.Y.K.; Begun, G.M.; Moody, R.L. Surface-Enhanced Raman Spectrometry for Trace Organic Analysis. Anal. Chem. 1984, 56, 1667–1670.
  41. Vo-Dinh, T. Surface-Enhanced Raman Spectroscopy Using Metallic Nanostructures. TrAC Trends Anal. Chem. 1998, 17, 557–582.
  42. Yan, F.; Wabuyele, M.B.; Griffin, G.D.; Vass, A.A.; Vo-Dinh, T. Surface-Enhanced Raman Scattering Detection of Chemical and Biological Agent Simulants. IEEE Sens. J. 2005, 5, 665–670.
  43. Chen, K.; Leona, M.; Vo-Dinh, T. Surface-enhanced Raman Scattering for Identification of Organic Pigments and Dyes in Works of Art and Cultural Heritage Material. Sens. Rev. 2007, 27, 109–120.
  44. Odion, R.; Liu, Y.; Vo-Dinh, T. Plasmonic Gold Nanostar-Mediated Photothermal Immunotherapy. IEEE J. Sel. Top. Quantum Electron. 2021, 27, 1–9.
  45. Huang, X.; El-Sayed, M.A. Gold Nanoparticles: Optical Properties and Implementations in Cancer Diagnosis and Photothermal Therapy. J. Adv. Res. 2010, 1, 13–28.
  46. Norton, S.J.; Vo-Dinh, T. Photothermal Effects of Plasmonic Metal Nanoparticles in a Fluid. J. Appl. Phys. 2016, 119, 083105.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
This entry is offline, you can click here to edit this entry!
ScholarVision Creations
Feedback